In a discourse on theology, “evil” is for certain scholars denoting the “absence of good.” When management, as being the totality of practices, technique, routines and standard operating procedures is perceived to do more harm than good, is it evil. Presents a narrative study of pharmaceutical research. According to a strategic management agenda, laboratory pre‐clinical research is seen as a core competence that delivers new chemical entities that become candidate drugs. Pharmaceutical researchers in discovery and development phases reject managerial practices because they in various ways limit scientific activities and impose control mechanisms. At the same time, pharmaceutical researchers emphasize the importance of leadership. The absence of genuine leadership and the emergence of managerial practices entailed a feeling of melancholia and loss of a successful past that will never be seen again, among the pharmaceutical researchers.
Article navigation
1 December 2003
Case Report|
December 01 2003
“Management is evil”: management control, technoscience and saudade in pharmaceutical research Available to Purchase
Alexander Styhre;
Alexander Styhre
Fenix Research Program, Chalmers University of Technology, Gothenburg, Sweden
Search for other works by this author on:
Mats Sundgren
Mats Sundgren
Fenix Research Program, Chalmers University of Technology, Gothenburg, Sweden
Search for other works by this author on:
Publisher: Emerald Publishing
Online ISSN: 1472-5347
Print ISSN: 0143-7739
© MCB UP Limited
2003
Leadership & Organization Development Journal (2003) 24 (8): 436–446.
Citation
Styhre A, Sundgren M (2003), "“Management is evil”: management control, technoscience and saudade in pharmaceutical research". Leadership & Organization Development Journal, Vol. 24 No. 8 pp. 436–446, doi: https://doi.org/10.1108/01437730310505867
Download citation file:
Suggested Reading
The state of public research on over‐the‐counter drug advertising
International Journal of Pharmaceutical and Healthcare Marketing (September,2010)
“Pressure points” on pharmaceutical industry executives: what lies ahead?
International Journal of Pharmaceutical and Healthcare Marketing (April,2009)
Off‐label drug use – price analysis for Avastin® in ophthalmology
International Journal of Pharmaceutical and Healthcare Marketing (April,2009)
For the drugs we need
Journal of Consumer Marketing (December,2005)
The order of entry effect in prescription (Rx) and over‐the‐counter (OTC) pharmaceutical drugs
International Journal of Pharmaceutical and Healthcare Marketing (April,2008)
Related Chapters
Ubiquity Without Clarity? What do We Mean by the ‘Higher Education Landscape’? A Systematic Review
Theory and Method in Higher Education Research
Metaphors on Women in Academia: A Review of the Literature, 2004–2013
At the Center: Feminism, Social Science and Knowledge
Soldier, Elder, Prisoner, Ward: Psychotropics in the Era of Transinstitutionalization
50 Years After Deinstitutionalization: Mental Illness in Contemporary Communities
Recommended for you
These recommendations are informed by your reading behaviors and indicated interests.
